These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32544477)

  • 1. Inflammasome Activation by CD8
    Cardoso TM; Lima JB; Bonyek-Silva Í; Nunes S; Feijó D; Almeida H; Silva J; Barral A; Boaventura V; Borges VM; Zamboni DS; Pedreira de Carvalho L; Carvalho EM; Tavares NM; Brodskyn C
    J Invest Dermatol; 2021 Jan; 141(1):209-213.e2. PubMed ID: 32544477
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles.
    Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL
    PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production.
    Novais FO; Carvalho AM; Clark ML; Carvalho LP; Beiting DP; Brodsky IE; Carvalho EM; Scott P
    PLoS Pathog; 2017 Feb; 13(2):e1006196. PubMed ID: 28192528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.
    Castro Gomes CM; Sousa MGT; Menezes JPB; Batista MC; Lima ACS; Belda W; Bradshaw D; Gama MEA; Laurenti MD; Silveira FT; Corbett CEP
    Parasitol Res; 2017 May; 116(5):1423-1431. PubMed ID: 28224222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of Potential CD4
    E Silva RF; de Oliveira BC; da Silva AA; Brelaz de Castro MCA; Ferreira LFGR; Hernandes MZ; de Brito MEF; de-Melo-Neto OP; Rezende AM; Pereira VRA
    Front Immunol; 2019; 10():3145. PubMed ID: 32117204
    [No Abstract]   [Full Text] [Related]  

  • 7. The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.
    Mendes-Aguiar Cde O; Gomes-Silva A; Nunes E; Pereira-Carvalho R; Nogueira RS; Oliveira-Neto Mde P; Bertho AL; Da-Cruz AM
    Clin Exp Immunol; 2009 Sep; 157(3):377-84. PubMed ID: 19664146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis.
    Santos Cda S; Boaventura V; Ribeiro Cardoso C; Tavares N; Lordelo MJ; Noronha A; Costa J; Borges VM; de Oliveira CI; Van Weyenbergh J; Barral A; Barral-Netto M; Brodskyn CI
    J Invest Dermatol; 2013 Jun; 133(6):1533-40. PubMed ID: 23321919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune response evaluation of cutaneous leishmaniasis patients cells stimulated with Leishmania (Viannia) braziliensis antigenic fractions before and after clinical cure.
    Brelaz-de-Castro MC; de Almeida AF; de Oliveira AP; de Assis-Souza M; da Rocha LF; Pereira VR
    Cell Immunol; 2012 Oct; 279(2):180-6. PubMed ID: 23246680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leishmania-reactive CD4+ and CD8+ T cells associated with cure of human cutaneous leishmaniasis.
    Da-Cruz AM; Conceição-Silva F; Bertho AL; Coutinho SG
    Infect Immun; 1994 Jun; 62(6):2614-8. PubMed ID: 7910596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis.
    Bittar RC; Nogueira RS; Vieira-Gonçalves R; Pinho-Ribeiro V; Mattos MS; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
    Mem Inst Oswaldo Cruz; 2007 Aug; 102(5):625-30. PubMed ID: 17710308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis.
    de Moura TR; Novais FO; Oliveira F; Clarêncio J; Noronha A; Barral A; Brodskyn C; de Oliveira CI
    Infect Immun; 2005 Sep; 73(9):5827-34. PubMed ID: 16113301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.
    Cardoso TM; Machado Á; Costa DL; Carvalho LP; Queiroz A; Machado P; Scott P; Carvalho EM; Bacellar O
    Infect Immun; 2015 Mar; 83(3):898-906. PubMed ID: 25534940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cells specific to leishmania and other nonrelated microbial antigens can migrate to human leishmaniasis skin lesions.
    Da-Cruz AM; Oliveira-Neto MP; Bertho AL; Mendes-Aguiar CO; Coutinho SG
    J Invest Dermatol; 2010 May; 130(5):1329-36. PubMed ID: 20107484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis.
    Campos MB; Lima LVDR; de Lima ACS; Vasconcelos Dos Santos T; Ramos PKS; Gomes CMC; Silveira FT
    PLoS One; 2018; 13(3):e0194383. PubMed ID: 29543867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to Lutzomyia whitmani Saliva Protects against Experimental Leishmania braziliensis Infection.
    Gomes R; Cavalcanti K; Teixeira C; Carvalho AM; Mattos PS; Cristal JR; Muniz AC; Miranda JC; de Oliveira CI; Barral A
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005078. PubMed ID: 27812113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8
    Fantecelle CH; Covre LP; Garcia de Moura R; Guedes HLM; Amorim CF; Scott P; Mosser D; Falqueto A; Akbar AN; Gomes DCO
    Immunology; 2021 Dec; 164(4):754-765. PubMed ID: 34432883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T cell activation by B cells in human Leishmania (Viannia) infection.
    Rodriguez-Pinto D; Saravia NG; McMahon-Pratt D
    BMC Infect Dis; 2014 Feb; 14():108. PubMed ID: 24568275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIM2 inflammasome is associated with disease severity in tegumentary leishmaniasis caused by Leishmania (V.) braziliensis.
    Moreira RB; Pirmez C; de Oliveira-Neto MP; Aguiar LS; Gonçalves AJS; Pereira LOR; Abreu L; De Oliveira MP
    Parasite Immunol; 2017 Jul; 39(7):. PubMed ID: 28397969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immune responses to Leishmania braziliensis in patients with AIDS-associated American cutaneous leishmaniasis.
    Da-Cruz AM; Mattos M; Oliveira-Neto MP; Coutinho Z; Machado ES; Coutinho SG
    Trans R Soc Trop Med Hyg; 2000; 94(5):569-71. PubMed ID: 11132391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.